Anacor Pharmaceuticals Inc Stock
Equities
US0324201013
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | Anacor Pharmaceuticals : received rival bid before Pfizer deal - filing | RE |
2016 | Anacor Pharmaceuticals : Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel | RE |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
Chief Tech/Sci/R&D Officer | 77 | 04-01-31 | |
Director/Board Member | - | 16-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
Bryan Supran
BRD | Director/Board Member | - | 16-06-23 |
Director/Board Member | - | 16-06-23 |
1st Jan change | Capi. | |
---|---|---|
+18.10% | 47.02B | |
+48.77% | 41.86B | |
+0.77% | 41.76B | |
-4.27% | 28.8B | |
+11.80% | 26.05B | |
-21.58% | 19.15B | |
+4.02% | 12.55B | |
+28.68% | 12.34B | |
-4.51% | 11.82B |
- Stock Market
- Equities
- Stock